Existing Account

Please login first to complete purchase/ quotation request, view custom order reports, or create favorites list.

Customer ID:
Stay Logged In

Forgot your Customer ID or Password?
New Account

Don't have an account with us yet? Please set up an account to place order or obtain customer services.

Assay Kits  >  Phosphatase Assay Kits  >>  SensoLyte® FDP Secreted Alkaline Phosphatase Reporter Gene Assay Kit *Fluorimetric*

Product Name SensoLyte® FDP Secreted Alkaline Phosphatase Reporter Gene Assay Kit *Fluorimetric*
Size 1 kit
Catalog # AS-71108
US$ $271.95

The secreted alkaline phosphatase (SEAP) is widely used as reporter gene to analyze the activity of promoters and transcriptional factors and to tract gene expression in cell culture or animals. SEAP can be effectively secreted into culture medium and serum. This unique characteristic of SEAP makes it convenient to kinetically analyze gene expression over a period of time using a single culture or animal. SensoLyte® FDP secreted alkaline phosphatase reporter gene assay kit provides a sensitive fluorimetric assay of placental alkaline phosphatase for both secreted and membrane-bound form of placental alkaline phosphatases. The kit contains: FDP fluorogenic substrate (Ex/Em=485±20/528±20 nm upon dephosphorylation), Assay buffer, Stop solution, A “mix and read” assay protocol that is compatible with high throughput screening liquid handling instruments

Kit size: 500 assays

Detailed Information Datasheet
Material Safety Data Sheets (MSDS)
Product Citations Zhu, B. et al. (2012). Calcification of primary human osteoblast cultures under flow conditions using polycaprolactone scaffolds for intravascular applications. J Tissue Eng Reg Med 6, 687. doi: 10.1002/term.472.

Zhou, J. et al. (2011). KLF15 activates hepatitis B virus gene expression and replication. Hepatology 10.1002/hep.24362.

Contreras-Ruiz, L. et al. (2011). Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells. Mol Vision 17, 279.
  < Back